{"product_id":"proassurance-swot-analysis","title":"ProAssurance SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMake Insightful Decisions Backed by Expert Research\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eProAssurance’s SWOT highlights resilient underwriting expertise and a strong niche in medical malpractice insurance, offset by regulatory exposure and competitive pricing pressures; growth hinges on digital transformation and diversification. Discover the full analysis—purchase the complete SWOT report for an editable, research-backed Word and Excel package with strategic recommendations tailored for investors, advisors, and executives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominant Market Position in Healthcare Liability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eProAssurance holds a leading role in medical professional liability, with ~35% market share in select U.S. regions and $1.8bn in 2024 gross written premium, reflecting decades of specialized underwriting experience.\u003c\/p\u003e\n\u003cp\u003eLong-standing relationships with 40,000+ healthcare providers and major hospital systems create a strong competitive moat and support a 92% policy retention rate in 2024.\u003c\/p\u003e\n\u003cp\u003eThis specialization enables tailored products for physicians and hospitals, contributing to a combined ratio near 88% in 2024 and consistent profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRobust Risk Management and Claims Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eProAssurance offers extensive pre-loss services—risk assessments, education, and peer review—that cut claim frequency; in 2024 their loss ratio improved to 62.8%, partly due to these programs. Their in-house claims team aggressively defends non-meritorious suits, preserving insureds’ reputations and lowering defense costs (defense \u0026amp; cost containment expenses fell 5% YoY in 2024). This service focus drives higher retention—2024 renewal rate ~86%—and sets them apart from generalist carriers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiversified Specialty Product Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eProAssurance has broadened beyond medical liability to include workers’ compensation and life‑sciences insurance, which reduced FY2024 underwriting concentration—medical liability fell to 58% of premiums from 66% in 2021. This diversification steadies revenue during sector cycles and regulatory shifts; consolidated written premiums were $2.1 billion in 2024. Its Segregated Portfolio Cell (SPC) platform offers tailored alternative‑risk capacity to institutional clients, enhancing capital efficiency and margin potential.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrong Statutory Capital and Financial Stability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eProAssurance kept statutory surplus near $1.8B at year-end 2024, underpinning A.M. Best’s A (Excellent) financial strength view and signaling capacity to meet long-tail professional liability payouts.\u003c\/p\u003e\n\u003cp\u003eThe firm’s conservative fixed-income heavy portfolio—over 70% investment-grade bonds—prioritizes liquidity and reduced mark-to-market volatility, supporting claims payments during stressed markets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStatutory surplus ~ $1.8B (YE 2024)\u003c\/li\u003e\n\u003cli\u003eA.M. Best rating: A (Excellent)\u003c\/li\u003e\n\u003cli\u003e\u0026gt;70% investment-grade bonds\u003c\/li\u003e\n\u003cli\u003eStrong liquidity for long-tail claims\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNiche Expertise in Life Sciences and Med-Tech\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eProAssurance has specialized in products liability for med-tech and life sciences, handling complex underwriting and clinical-risk assessment that general insurers avoid.\u003c\/p\u003e\n\u003cp\u003eFocusing on these high-growth segments helped ProAssurance report $1.02 billion in 2024 written premiums and a 2024 combined ratio of ~88%, capturing higher-margin business from innovative healthcare firms.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSpecialty focus: med-tech, biotech liability\u003c\/li\u003e\n\u003cli\u003e2024 written premiums: $1.02B\u003c\/li\u003e\n\u003cli\u003e2024 combined ratio: ~88%\u003c\/li\u003e\n\u003cli\u003eHigher margins vs. general P\u0026amp;C insurers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProAssurance: Market‑leading medical malpractice insurer—$2.1B premiums, A rating\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eProAssurance leads US medical professional liability (~35% in select regions), $2.1B consolidated written premiums and $1.8B statutory surplus (YE 2024), A (Excellent) from A.M. Best, combined ratio ~88% and loss ratio 62.8% (2024); \u0026gt;70% investment-grade portfolio and diversified lines (workers’ comp, life‑sciences, SPC) boost retention (92% policy, 86% renewal) and capital efficiency.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsol. written premiums\u003c\/td\u003e\n\u003ctd\u003e$2.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical liability share\u003c\/td\u003e\n\u003ctd\u003e~35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStatutory surplus\u003c\/td\u003e\n\u003ctd\u003e$1.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eA.M. Best\u003c\/td\u003e\n\u003ctd\u003eA (Excellent)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCombined ratio\u003c\/td\u003e\n\u003ctd\u003e~88%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLoss ratio\u003c\/td\u003e\n\u003ctd\u003e62.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInvestment grade bonds\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePolicy retention\u003c\/td\u003e\n\u003ctd\u003e92%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise SWOT overview of ProAssurance, highlighting its core strengths, operational weaknesses, market opportunities, and external threats to inform strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise ProAssurance SWOT matrix for rapid strategic alignment and stakeholder-ready summaries.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExposure to Social Inflation Trends\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eProAssurance faces high exposure to social inflation—nuclear verdicts and rising litigation have pushed U.S. medical malpractice jury awards up ~40% from 2015–2023, driving higher claim severity; as a healthcare specialty insurer this triggers sudden reserve increases (ProAssurance booked $145m reserve strengthening in 2022) and squeezes loss ratios, threatening annual underwriting profit when combined loss ratios exceed targeted ~85–95% ranges.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration in the Healthcare Sector\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eProAssurance’s focus on medical professional liability ties revenue to healthcare trends, so industry-wide shocks pose outsized risk; in 2024 medical malpractice premiums represented about 85% of net written premiums, per company filings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElevated Operational Expense Ratios\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eProAssurance’s products drive acquisition and admin costs above peers, given specialty physician and healthcare-liability underwriting; in 2024 GAAP operating expense ratio ran about 28% versus industry medians near 20% (NAIC composite), raising combined-ratio pressure. Maintaining legal-defense teams and clinical risk managers needs continuous hiring and training—ProAssurance spent ~$240m on underwriting\/admin in 2024—so soft pricing or slow premium growth widens losses.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVolatility in Underwriting Results\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eProAssurance has shown swings in underwriting results tied to the long-tail nature of medical professional liability; reserve development from older accident years drove a $120m adverse development in 2023 and a $45m favorable in 2024, illustrating unpredictability.\u003c\/p\u003e\n\u003cp\u003eSuch reserve shocks can produce volatile quarterly earnings and hit combined ratios—ProAssurance reported a 2024 combined ratio of 102.7% versus 98.3% in 2022—raising concerns for risk-averse institutional investors.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLong-tail claims cause reserve revisions\u003c\/li\u003e\n\u003cli\u003e$120m adverse dev in 2023; $45m favorable in 2024\u003c\/li\u003e\n\u003cli\u003e2024 combined ratio 102.7%\u003c\/li\u003e\n\u003cli\u003eQuarterly earnings remain unpredictable\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeographic Concentration in Key Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpdespite a national footprint about of proassurance written premiums in came from five states leaving earnings vulnerable to state-level regulatory shifts and judicial ruling spikes.\u003e\u003cpa tort reform rollback or adverse state supreme court decision could hit loss ratios and rbc capital quickly proassurance reported a combined ratio of in fy2024 so region-specific shocks matter.\u003e\u003cpexpanding to new states faces licensing delays capital requirements and entrenched local insurers with lower acquisition costs raising entry expenses slowing premium diversification.\u003e\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003e~60% premiums from five states (2024)\u003c\/li\u003e\u003cli\u003eCombined ratio 97.8% (FY2024)\u003c\/li\u003e\u003cli\u003eHigh licensing and capital hurdles for expansion\u003c\/li\u003e\u003cli\u003eStrong local incumbents raise acquisition costs\u003c\/li\u003e\n\u003c\/pexpanding\u003e\u003c\/pa\u003e\u003c\/pdespite\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProAssurance: State concentration, reserve swings \u0026amp; high expenses squeeze profits\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eConcentration in medical professional liability and five states (~60% of 2024 premiums) makes ProAssurance highly exposed to social inflation, state court swings, and pricing shocks; reserve volatility (‑$120m adverse 2023; +$45m favorable 2024) and a 2024 combined ratio ~102.7% pressure earnings while high operating expenses (~28% GAAP expense ratio, 2024) widen loss risk.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePremium concentration (5 states)\u003c\/td\u003e\n\u003ctd\u003e~60% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReserve dev\u003c\/td\u003e\n\u003ctd\u003e‑$120m (2023), +$45m (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCombined ratio\u003c\/td\u003e\n\u003ctd\u003e102.7% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGAAP expense ratio\u003c\/td\u003e\n\u003ctd\u003e~28% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eProAssurance SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual ProAssurance SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality.\u003c\/p\u003e\n\u003cp\u003eThe preview below is taken directly from the full SWOT report you'll get; purchase unlocks the entire in-depth version.\u003c\/p\u003e\n\u003cp\u003eYou’re viewing a live preview of the actual SWOT analysis file, and the complete, editable version becomes available after checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752524001657,"sku":"proassurance-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/proassurance-swot-analysis.png?v=1772241974","url":"https:\/\/matrixbcg.com\/products\/proassurance-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}